NL-OMON54462招募中2 期
ormothermic Machine perfusion: an additional value for kidney transplant outcomes? - APOLLO study
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 入组人数
- 80
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •Kidney related:
- •In order to be eligible to participate in this study, the donor kidney must
- •meet the following criteria:
- •- Donation after Circulatory Death (DCD) type III/IV/V (Maastricht criteria) OR
- •- Donation after Brain Death (DBD) donor kidney IF the kidney meets ECD
- •o Donor >=60, OR
- •o Donor 50-59 years with 2 of the following risk factors: history of high blood
- •pressure, creatinine greater than or equal to 1.5 mg/dl (133 umol/l), death
- •resulting from stroke.
- •Recipient related:
- •- Adult (>=18 years old) recipients.
- •- Mentally competent recipients.
- •- Recipients who receive renal replacement therapy at the moment of
- •transplantation.
- •- Recipients who provided written informed consent.
排除标准
- •- Multi-organ transplant recipients (such as combined liver/kidney).
- •- Receiving a donor kidney preserved on static cold storage.
- •- Receiving a donor kidney that is explanted after normothermic regional
- •- DCD type I and II (Maastricht criteria).
- •- Dual kidney transplantation
- •- The patient receives another immunosuppression regime than standard-of-care
- •(which is induction with basiliximab followed by triple therapy with
- •tacrolimus, mycofenolate mofetil and prednisone)
研究者
相似试验
招募中
不适用
Prolonged ex-vivo normothermic machine perfusion for kidney regeneratioPatients with end-stage renal disease undergoing a kidney transplantationNL-OMON26491eiden University Medical Center18
招募中
2 期
PROlonged ex-vivo normothermic machine PERfusion for kidney regeneratiokidney transplantation1002914910038365NL-OMON52366eids Universitair Medisch Centrum18
Unknown
不适用
PROlonged Ex-vivo Normothermic Machine PERfusion for Kidney RegenerationEnd Stage Renal DiseaseNCT04693325Leiden University Medical Center18
招募中
不适用
The applicability of machine perfusion preservation by the Airdrive system in kidney transplantation.The patiënts which are to be included in this study have kidney problems which can only be treated by kidney replacement therapy In this pilot we do not study the underlying disease We study the safety of a new machine perfusion systemNL-OMON22914Academic Medical Center AmsterdamMeibergdreef 91105 AZAmsterdam7
招募中
不适用
DHOPE-PRO TrialNL-OMON28242MCG36